FOXG1 (Forkhead Box G1) is located on a single exon in chromosome 14q12 that encodes a forkhead family transcriptional repressor. The FOXG1 protein is highly expressed in the developing forebrain (telencephalon) and is critical for early brain development. It contains an N-terminal region rich in polyhistidine and polyproline/glutamine segments, a conserved forkhead DNA-binding domain, and C-terminal domains that interact with co-repressors, specifically the Groucho/TLE and JARID1 family proteins, to modulate gene expression. FOXG1 regulates a network of developmental genes. Although it acts as a transcriptional repressor, it also has context-dependent activating effects. For example, FOXG1 directly binds neuronal and oligodendroglial gene promoters, cooperating with other transcription factors (e.g. ZBTB18, bHLH factors, NF1) to influence cortical neuronal and glial cell differentiation. Pathogenic FOXG1 variants are usually de novo and cause haploinsufficiency or dysfunctional protein products. The majority are loss-of-function (frameshift, nonsense) or missense mutations, as well as whole-gene deletions or duplications. Notably, frameshift mutations are frequent (~40% of cases) and tend to cluster in GC-rich “hotspots” within the N-terminal coding region (before the forkhead domain). Because FOXG1 has no introns, truncating mutations can still express dysfunctional proteins.
Missense mutations (often retaining partial protein function) generally lead to milder phenotypes than null or truncating mutations. For example, patients with missense variants more frequently attain motor milestones (sitting, walking) and have lower incidence of epilepsy compared to those with FOXG1 deletions or early truncating variants. Furthermore, truncating mutations that spare the forkhead DNA-binding domain (occurring in the C-terminal region) are associated with better developmental outcomes than truncations in the N-terminus, presumably due to some residual FOXG1 activity. Thus, depending on variant type and location, the FOXG1 phenotype can be heterogeneous in terms of severity and phenotypic presentations.
Recent research provides insight into how FOXG1 mutations disrupt neurodevelopment. A 2025 patient-specific knock-in mouse model carrying a common human frameshift mutation (Q86Pfs in FOXG1) revealed that the mutant allele produces a truncated N-terminal fragment of FOXG1. This fragment can dimerize with and mislocalize the wild-type FOXG1 protein, forming intranuclear aggregates and sequestering the normal protein away from its genomic targets. Consistent with this, affected knock-in mice show an accumulation of neural progenitors and a deficit of mature neurons, along with disrupted cortical layering. FOXG1 mutations also perturb the balance of excitatory and inhibitory neurons and impair oligodendrocyte development in the brain.
FOXG1